Why Seven Hormones in One Well Transforms Metabolic Research

Glucose homeostasis is not regulated by any single hormone — it emerges from the coordinated, antagonistic, and temporally orchestrated actions of the enteroinsular axis. Insulin and glucagon are functional antagonists at the liver. GLP-1 and GIP potentiate insulin secretion (the incretin effect) while suppressing glucagon. Leptin signals long-term energy status to the hypothalamus. PYY suppresses appetite and slows gastric emptying. C-peptide distinguishes endogenous insulin secretion from exogenous administration. Measuring any subset in isolation produces an incomplete — and potentially misleading — picture of metabolic state.

Research Applications of the 7-Plex

  • Diabetes & insulin resistance research: Simultaneous insulin, glucagon, C-peptide, and GLP-1 enables calculation of HOMA-IR, insulin:glucagon ratio, and the incretin effect — core metabolic parameters that require coordinated measurement of multiple hormones.
  • GLP-1 receptor agonist & DPP-IV inhibitor pharmacology: Active GLP-1 (Panel 2) quantifies the pharmacodynamic effect of DPP-IV inhibition and GLP-1R agonism; insulin and glucagon provide the downstream metabolic readout.
  • Bariatric & metabolic surgery research: GLP-1, PYY, and GIP are dramatically elevated after Roux-en-Y gastric bypass and sleeve gastrectomy; the 7-Plex captures the full post-surgical hormonal shift from a single sample.
  • Meal tolerance & glucose clamp studies: Serial 7-Plex measurements during metabolic challenges provide dynamic hormone response curves — insulin secretion rate, incretin effect magnitude, glucagon suppression — from minimal plasma volume at each timepoint.
  • Epidemiological & cohort studies: The 7-Plex's V-PLEX lot-to-lot bridging supports multi-year longitudinal metabolic phenotyping with documented analytical continuity across reagent transitions.